| Logo | Name | Σ | Employees |
|---|---|---|---|
 |  Adaptimmune Designing and delivering cell therapies to transform the lives of people with cancer. Adaptimmune is a fully integrated cell therapy company, designed and built from the ground up with four U.K.- and U.S.-based biotechnology hub locations. Our comprehensive capabilities and teams include preclinical research, clinical development, translational sciences, autologous and allogeneic manufacturing, and in-house commercial and corporate operations. For more information about Adaptimmune, please visit www.adaptimmune.com. If interested in joining our fast growing team, click on the careers tab of this page. Adaptimmune only accepts employment applications through our corporate website at Adaptimmune.com/Careers and through the ‘Easy Apply’ feature on … 62 similar entities Type: SMB Activities: deeptech biotech Technologies: Synthetic Biology | 1 | 526 |
 |  CELLforCURE by Seqens Trustworthy development and commercial manufacturing of CELL&GENE therapies On december 1st 2023, Seqens completed the acquisition of CELLforCURE. Originally a versatile CELL&GENE CDMO, CELLforCURE gained thorough experience in commercial CAR-T cells manufacturing. With 2 200m2 GMP production areas, 6 equipped production suites and 180 seasoned highly skilled experts, CELLforCURE offers versatile and flexible capacities. Located in France, 20km away from the Paris Orly Airport, CELLforCURE is an EMA approved production site and is compliant with FDA standards. The site brings analytical, development and regulatory services to serve client needs across the overall product life cycle. CELLforCURE teams aim at partnering … 21 similar entities Type: Startup Activities: manufacturing deeptech Technologies: Synthetic Biology | 7 | 100 |
 | Advesya Transforming cancer and autoimmune treatments with unique IL-1RAP targeting approaches Advesya is a pioneering and transformative biotechnology company developing therapies for difficult-to-treat cancers. Haematology & Oncology, Antibody Drug Conjugate, Cell Therapy, and Autoimmune 398 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 11 | 14 |
 | Priothera SAS Adding Quality Years of Life We are dedicated to improving the lives of patients suffering from hematological malignancies by delivering an innovative immune modulator to enhance the curative potential of allogeneic Hematopoietic Stem Cell Transplantation (HSCT) 207 similar entities Type: Startup Activities: biotech deeptech healthtech Technologies: Synthetic Biology | 15 | 20 |
 |  Nano3D Biosciences Nano3D Biosciences (n3D) is a biotechnology startup located in Houston, TX focused on 3D cell culture solutions for biomedical research, drug discovery, toxicology, precision medicine, and regenerative medicine. Our core technology, magnetic 3D bioprinting, works by magnetizing cells and aggregating them with magnetic forces into models that represent native tissue environments. The advantages of this platform over other 3D cell culture and bioprinting platforms are speed, ease, and handling. n3D offers products and services around this technology, with a worldwide distribution network, including an OEM partnership with Greiner Bio-One Cell culture, Assay development, 3D cell culture, Precision medicine, Toxicology, and … 40 similar entities Type: Startup Activities: biotech healthtech deeptech Technologies: 3D Printing Synthetic Biology | 1 | 2 |
 | AdhexPharma We deliver solutions AdhexPharma is an independent drug delivery company specialized in Transdermal & Topical patches and Oral Thin Films technologies. AdhexPharma is based in France, with GMP manufacturing facility for European and US market. We have 4 approved products in Europe and North America and a pipeline of 6 candidates, ranging from 505(b)2 / NDA and ANDA in different therapeutical areas: pain, CNS, anesthesia, smoking cessation and HRT. Trandermal, Patch, Oral Thin Film, Drug Development, GMP manufacturing, FDA approved, OTF, ODF, cGMP, TDS, CDMO, and CMO 61 similar entities Type: Startup Activities: biotech deeptech manufacturing Technologies: Synthetic Biology | 16 | 148 |
 | MPC Therapeutics Biotech company focused on cellular rejuvenation to fight cancer & degenerative pathologies. At MPC Therapeutics, we are convinced that mitochondria, the small organelles at the core of the cell's metabolism, represent untapped therapeutic targets. Headquartered in Switzerland, our startup is focused on cellular rejuvenation to improve the performance of cell therapies and treat degenerative pathologies. Our novel approach uses proprietary first-in-class small molecules that specifically target mitochondria to trigger metabolic reprogramming. Visit our website for more info. Longevity, Mitochondria, Cellular rejuvenation, Immunotherapy, and CAR T cell therapy 37 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 1 | 7 |
 | Devicare The Digital Therapeutic Company in Urology Devicare is a specialty biotech company dedicated to develop pathbreaking medical treatments in Urology combining the most recent scientific advances in nutritional therapy with digital technologies. Biotechnology, Medical devices , Digital Health , eHealth, Healthcare, and Digital Therapeutics 383 similar entities Type: Startup Activities: biotech deeptech healthtech Technologies: Synthetic Biology | 7 | 31 |
 | GTP Bioways - Olon Company Customer-centric and science-driven CDMO supporting biopharma companies from R&D to market GTP Bioways is an expert and fast-growing contract development and manufacturing organisation (CDMO) offering uniquely customised process development and manufacturing services for biologics, antibody-drug conjugates and nanodrugs. With cutting-edge facilities located in France, GTP Bioways supports biopharma companies in bringing their innovative molecules from research to clinic and market. GTP Bioways is an Olon company. Biologics, Nanodrugs, Process Development, Analytics, Biopharmaceuticals, and GMP Manufacturing 61 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 24 | 157 |
 | TISSIUM Biomorphic Programmable Polymers TISSIUM was founded in 2013 to address one of the most persistent medical challenges since the inception of surgical procedures: to reconstruct damaged tissue and restore its natural function. Since the discovery of our first polymer at the labs of Bob Langer and Jeff Karp at MIT, we recognized the exceptional potential for our technology to revolutionize the field of tissue reconstruction in multiple therapeutic areas. Our unique approach to product development leverages the knowledge gained from the development of our technology platform comprised of proprietary polymers, activation technologies, and delivery devices. We have developed a fully … 83 similar entities Tags: FrenchTech120 Type: Startup Activities: biotech deeptech healthtech Technologies: Synthetic Biology | 18 | 132 |
 | InVenis Biotherapies Platelet-derived Regenerative Therapy for CNS Disorders InVenis Biotherapies is a biotech compagny, spin-off from academic laboratory U1172 and Taipei Medical University, developping innovative regenerative therapies based on blood platelet. Thanks to the high therapeutic potential of our product, we target the most severe diseases involving cell death, as the amyotrophic lateral sclerosis. 217 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 7 | 2 |
 | Made Scientific Defy Limits. Deliver Results. Made Scientific is a leading cell therapy contract development and manufacturing organization (CDMO) dedicated to advancing the field of cell therapy. Since 2019, the company has specialized in developing, manufacturing, and releasing autologous and allogeneic cell therapy products for early- to mid-stage clinical trials, and has evolved into an end-to-end clinical-to-commercial service provider. Operating from two U.S.-based manufacturing facilities, Made Scientific combines the flexibility and entrepreneurial spirit of a specialist CDMO with the global expertise and resources of GC Corporation of South Korea, a global leader in the pharmaceutical and biotechnology sectors. CDMO, Process Development, Analytical … 88 similar entities Type: Startup Activities: manufacturing biotech deeptech Technologies: Synthetic Biology | 3 | 73 |
 | Century Therapeutics, Inc Harnessing the power of adult stem cells to develop curative therapies for cancer and autoimmune diseases Our genetically engineered, iPSC-derived cell products are designed to specifically target hematologic and solid tumor cancers, with a broadening application to autoimmune diseases. We are leveraging our expertise in cellular reprogramming, genetic engineering, and manufacturing to develop therapies with the potential to overcome many of the challenges inherent to cell therapy and provide a significant advantage over existing cell therapy technologies. We believe our commitment to developing off-the-shelf cell therapies will expand patient access and provide an unparalleled opportunity to advance the course of … 100 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 2 | 178 |
 | AuriGen Medical Delivering Hope to the Heart of our Patients AuriGen Medical are an EUeic supported medical device start up, developing the next generation in left atrial appendage implant technology for the treatment of medication resistant longstanding persistent atrial fibrillation. #EUeic #eicAccelerator 10 similar entities Type: Startup Activities: deeptech healthtech Technologies: Synthetic Biology | 1 | 16 |
 | PROTEIGENE PROTEIGENE (https://proteigene.com/) deals with scientific products and technologies since 1999. During more than 20 years, we delivered high level technology systems like Qbot/Qpix, Clonepix FL, Fragment analyzer, ImageStreamX , SeaHorse analysers and many others. Today, we still propose powerfull systems and consummables in Single Cell Analysis, Cell line development and Antibody research, Numeric NGS, Multi Omics plateform , targeted metabolomics, lab in a cell devices... Cyto-Mine by Sphere Fluidics, GenapSys, A4Cell technology Biocrates kits Sengenics Immunoprofiling services Robotics S-LAb from PAA and others. https://proteigene.com/ Biologie Moléculaire, Biologie Cellulaire, Métabolomique, Proteomique, Single cell Analysis, and NGS 61 similar entities Type: SMB Activities: deeptech biotech Technologies: Robotics | 1 | 8 |
 | Graftys Founded in 2005, Graftys develops, manufactures and markets patented synthetic bone biomaterials, in particular new generations of resorbable calcium-phosphate cements, for reconstructive orthopedic surgery. The Company’s products are commercialized in more than 25 countries, including Europe and the United States of America, through distribution partnership. The objective of the Company is to expand the Company product lines by offering new versions of existing products and new products with enhanced regenerative properties. The Company is based in Belgium (Wallonia) and France (Nantes and Aix-En-Provence). bone graft substitutes, Bone void fillers, Orthopedics, Reconstructive orthopedic surgery, Trauma, Bone tissue engineering, Injectable bone substitutes, … 43 similar entities Type: SMB Activities: deeptech manufacturing Technologies: Synthetic Biology | 2 | 16 |
 | Cellforcure a NOVARTIS company CELLforCURE gathers all cell and gene therapies activities of the LFB group. With an annual production capability of several thousands of therapeutics batches, the Les Ulis CELLforCURE facility is the first modular entity in Europe to enable large scale industrial production for ATMPs. This platform operates on a mixed model of a CDMO (Contract Development and Manufacturing Organisation) providing large scale GMP and cGMP production services, for both clinical and commercial needs, and of a pharmaceutical company leading the development of cell and gene therapies medicinal products up to their launch on the market. CELLforCURE is an … 87 similar entities Type: Startup Activities: healthtech manufacturing deeptech biotech Technologies: Synthetic Biology | 2 | 104 |
 | a4cell Lab-in-a-cell-devices Dynamic film about cell sensing SPAchip® technology is based on intracellular silicon microchips printed with multiple fluorescent probes to analyse and monitor cellular pathways at real time intracellular processes. The cell-based assays based on SPAchip® are compatible with High Content Screening platforms and imaging analysers. Suspended planar arrays, single cell analysis, cell signaling, flow cytometry, vaccines, and immunothepary 66 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 2 | 18 |
 | CEMA Technologies Technologies for Efficient Tooling For more than 50 years we manufacture multi-cavity molds (>128) for drug delivery devices. plastique, moule d'injection, injection mold, medical, diagnostic, pharmaceutical, design control, and metrology 90 similar entities Type: SMB Activities: deeptech Technologies: Synthetic Biology | 6 | 39 |
 | Bionoveo Research center & amp; Health development Bionoveo offers project leaders, industrial or academic, biological, technical and methodological skills and resources necessary for the development of new therapeutic and diagnostic strategies, as well as their production processes. 283 similar entities Type: SMB Activities: deeptech Technologies: Synthetic Biology | 5 | 4 |
 | RoslinCT Your Advanced Cell & Gene Therapy CDMO Partner RoslinCT is a leading global contract development and manufacturing services organization (CDMO) focused on Advanced Cell and Gene Therapies. Established in 2006 and built upon the groundbreaking technology cloning of Dolly the Sheep at the Roslin Institute in 1997, RoslinCT has harnessed cutting-edge science to advance the development of human medicines. With a remarkable heritage in the field, the company has achieved significant milestones, including being among the first in the world to produce clinical-grade human pluripotent stem cells and advancing the first CRISPR-edited stem cell-based therapy for a major disease to … 63 similar entities Type: Startup Activities: biotech deeptech manufacturing Technologies: Synthetic Biology | 4 | 418 |
 | Naobios Biomanufacturing services Naobios provides bioprocess development and contract manufacturing services for viral vaccines and viral vectors. The company was acquired by Clean Biologics on March 1st, 2019 and now supports clients for process development and the manufacture of preclinical and clinical batches. 159 similar entities Type: Startup Activities: manufacturing deeptech Technologies: Synthetic Biology | 8 | 39 |
 | Healshape A regenerative medecine company Healshape is a regenerative medecine project. We aim at developing breast regeneration solutions by 3D bioprinting for women who had mastectomy following breast cancer. Biotechnology, Regenerative medecine, Médecine régénérative, Reconstruction mammaire, Cancer du sein, Breast cancer, Breast regeneration, Breast reconstruction, 3D bioprinting, Tissue engineering, Biologie cellulaire, Impression 3D, Funds raising, and Tissue engineered products 61 similar entities Type: Startup Activities: deeptech Technologies: 3D Printing Synthetic Biology | 23 | 23 |
 | Cell&Soft Soft culture plates for pleased cells Cell&Soft is a young french biotech located in the AURA region, in Grenoble city. Born from a joint project between LTM Lab (CNRS) and CEA BIG, Cell&Soft is specialized in the development, production and sale of soft and biomechanical substrates for in vitro cell culture. Cell&Soft offers solutions to enhance the physiology and the relevance of cell culture and cell-based assays. biotechnology, cell culture, soft substrates, culture plates, cell-based assays, biotech, in vitro, drug discovery, stem cells, controlled rigidity, controlled stiffness, and petri dish 35 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 4 | 6 |
 | MarraBio Building Better Biology At MarraBio we design, engineer and construct bacterial protein polymers, that contain the biological messages that cells need to grow, divide and behave properly. Cells grown on an industrial scale for research, agricultural or therapeutic use need to be supplied with the right signals. We provide a multi-functional, cost effective solution in a single, easy to use material. Find out more at https://www.marrabio.com/ Protein Engineering, Protein Production, Cellular Agriculture, Cultivated Meat, Research Reagents, Stem Cell Expansion, and Industrial Scale Cell Culture 138 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 1 | 9 |
 | Pencil Biosciences Limited Developing the Next Generation Gene Editing Technology Pencil Biosciences is developing a truly innovative gene modulation technology that can have an impact across a range of applications, including new therapeutic options for patients with rare diseases. Genome Engineering, Research and Development, and Gene Editing 299 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 0 | 16 |
 | Molecular Templates Engineering the Next Generation of Therapeutics Molecular Templates, Inc. (MTEM) is a clinical stage biopharmaceutical company focused on the discovery and development of biologic therapeutics for the treatment of cancer and other serious diseases. The company primarily develops a pipeline of therapies through its proprietary biologic engineered toxin body (ETB) drug platform with unique mechanisms of actions which are highly differentiated from antibody drug conjugates (ADCs). MTEM is developing MT-6402, which is in a Phase I clinical trial for PD-1/PD-L1 antibody relapsed/refractory patients; MT-5111, which is in a Phase I clinical trial for the treatment of HER2-positive cancers; and MT-0169, … 42 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 1 | 33 |
 | Phenocell Phenocell is a research-based biotechnology company specialized in the creation, production, and commercialization of cellular models & bioassays for research and drug discovery. We are your designated partner for open innovation projects, let's reach out! Using the Nobel-prize winning technology of cellular reprogramming, we create foot-print free, feeder-free, hiPSC that are further differentiated into somatic cells and amenable to 3D projects. Large batches of qualified cells can be produced and used in unique phenotypic assays to repurpose existing drugs or discover new compounds. Phenocell has specific expertise in the production of: -human skin cells: sebocytes, melanocytes and keratinocytes -human retinal … 67 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 2 | 10 |
 | Cell-Easy Your Cell-Therapy Specialized CDMO Cell-Easy is a CDMO specialized in Cell Therapy. We support biotech, pharma, and public institutions with GMP development and manufacturing. Our mission: accelerate your Cell Therapy’s path to market, with patient access as our priority. ATMPs are not conventional biologics — they are living drugs. Our team brings hands-on expertise in cell culture across all cell types, engineered or not, addressing challenges in development, GMP manufacturing, and QC. Beyond core CDMO services — process diagnostics, development, GMP production, cell banking, cryostorage, and delivery — we also support sourcing of human biological materials and clinical trial setup, … 80 similar entities Type: Startup Activities: biotech healthtech manufacturing Technologies: Synthetic Biology | 1 | 36 |
 | CellProthera SAS Pionnier de la thérapie régénératrice cardiaque CellProthera, a biotechnological company, has developed a unique therapeutic technique which enables the structural and functional regeneration of severe post-infarctus cardiac lesions. After European and national (FR/GB) authorization was obtained , CellProthera has started its I/IIB clinical trial in Humans. Heart Regeneration Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 16 | 24 |
 | Dyameo Dyameo is a research company & amp; Development in the field of medical devices which designs aid probes for the diagnosis of in-vivo cancer cells. This medical device, makes it possible to answer the question: "Are these cells cancerous?", And that in a simple, clear and instant manner. This rupture solution proposes to discriminate cancer cells at an early stage, during endoscopic examinations. Medical devices, medtech, and help with in-vivo cancer diantics 63 similar entities Type: Startup Activities: biotech deeptech manufacturing Technologies: Synthetic Biology | 4 | 8 |
 | Astraveus We build high tech equipment supporting end-to-end development and manufacture of cell and gene therapies. We build high tech equipment supporting end-to-end development and manufacture of cell and gene therapies. biotech, medtech, cell therapy, gene therapy, CAR-T, MSC, iPS, ATMP, Tissue Engineering, cell based therapies, biotherapies, RMAT, and Manufacturing 428 similar entities Tags: FrenchTech2030 Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 15 | 66 |
 | Okomera Automated 3D organoid screening technology We integrate standard assays on chip (eg. CRISPR, T-cell, cytotoxicity) to accelerate drug discovery from target to validation, and advance preclinical predictivity 333 similar entities Type: Startup Activities: biotech deeptech healthtech Technologies: Synthetic Biology | 38 | 30 |
 | TreeFrog Therapeutics Cell Therapy for All TreeFrog Therapeutics is a French-based biotech company aiming to unlock access to cell therapies for millions of patients. TreeFrog Therapeutics is developing a pipeline of therapeutic candidates using proprietary C-Stem technology, allowing for the mass production of induced pluripotent stem cells and their differentiation into ready-to-transplant microtissues with unprecedented scalability and cell quality. Bringing together over 150 biophysicists, cell biologists and bioproduction engineers, TreeFrog Therapeutics raised $82M in 2021 to advance its pipeline of stem cell-based therapies in the field of regenerative medicine with the lead program in Parkinson's Disease. In 2022, the company opened a … 52 similar entities Tags: FrenchTech120 FrenchTech2030 Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 51 | 178 |
 | Berkeley Lights Berkeley Lights is now part of Bruker Cellular Analysis Berkeley Lights is now part of Bruker Cellular Analysis biotech, single cell, micro-fluidics, cancer genomics, human oncology, life science, optics, molecular biology, and oncology 130 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 12 | 39 |
 | Oxyledger Reinvent the traceability of implantable medical devices to democratize and simplify clinical follow-up Our mission: Build secured and protected global Medical Device Health Registry by collecting data at the point of use in the Operating Room for practicing evidence-based medicine and tracing implantable devices to protect patient safety and meet regulatory compliance. Traçabilité, Santé, Prothèses, Dispositifs médicaux, Implants, DMI, IUD, DM, Wiki, Bloc opératoire, GS1, UDI, and Wiki 138 similar entities Type: Startup Activities: manufacturing healthtech deeptech Technologies: Synthetic Biology | 10 | 10 |
 | Meccellis Biotech French manufacturer of biologic implants Meccellis Biotech is a company expert in Tissue and Cell Engineering with a diversified offer for multiple surgical specialties. After 7 years of marketing, Meccellis Biotech is now present in 25 countries. The passion and professionalism of its teams have made of Meccellis Biotech, a reference company for the manufacturing of biomaterials. For any further information you may need regarding our range of biologic implants, please feel free to contact us: contact@meccellis.com - Phone number: +33 (0) 5 17 81 07 63 - THE MECCELLIS BIOTECH TEAM Breast reconstruction: CELLIS Breast, General surgery: CELLIS, and … 20 similar entities Type: Startup Activities: deeptech healthtech manufacturing Technologies: Synthetic Biology | 12 | 11 |
 | StarkAge Therapeutics Immunotherapy against senescence StarkAge Therapeutics is a privately-held biotechnology start-up, whose ambition is to delay or halt disease progression and improve quality of life of patients with age-related diseases, associated with senescent cells accumulation. It builds on its unique disease-specific exosomal / EV technology while harnessing immunotherapy approach, to address very large senescence unmet medical needs. 69 similar entities Type: Startup Activities: biotech deeptech healthtech Technologies: Synthetic Biology | 2 | 11 |
 | Myonex Creapharm, a Myonex company, offers capabilities and flexibility to serve pharmaceutical and biotech companies in both clinical and commercial stages, including companies managing advanced therapies. Beyond decades of experience in Clinical Trial Supply Management, we provide a strong expertise in cold-chain management and recently developed ultra-cold solutions to handle biologicals and ATMP supply chain. For marketed health products, we offer expert commercial packaging services. More globally, Myonex is established throughout Europe (France, Germany and Denmark), UK and in the USA. Clinical GMP Production, Clinical Packaging, Distribution Distribution, International Depot Network, IMP Sourcing and Importation, and Biological sampling kit production 102 similar entities Type: SMB Activities: deeptech Technologies: Synthetic Biology | 14 | 341 |
 | Jurata Revolutionizing the storage and delivery of vaccines and therapeutics. We are a biotechnology company revolutionizing vaccines and biologics by removing all cold storage requirements and expediting manufacturing. 83 similar entities Type: Startup Activities: deeptech Technologies: Synthetic Biology | 1 | 17 |
 | Volumina Medical Addressing the problem of natural repair of soft tissues with injectable 3D scaffolds Volumina Medical is a multi-award-winning start-up active in the field of medical devices supported by a solid network of investors. The company develops breakthrough innovations for plastic and reconstructive surgery. The first product is an implantable polymeric biomaterial and targets the regeneration of soft tissue of the human body which are damaged after tumor excision, genetic malformation or trauma. Implants, Biomaterial, and Regenerative Medicine 96 similar entities Type: Startup Activities: deeptech healthtech Technologies: Synthetic Biology | 2 | 13 |
 | LabSkin Creations Your Skin Designer LabSkin Creations is a biotechnology company specializing in advanced 3D skin and adipose tissue engineering. By combining innovative cell culture techniques as well as proprietary technologies based on scaffolding biomaterials and 3D bioprinting approaches, LabSkin designs and creates unique and versatile 3D reconstructed models for the performance evaluation of skin and personal care products and their ingredients. tests d'activité et d'efficacité, analyse d'image, Histologie, Immunohistochimie, Biologie cutanée, 3D, Reconstructed skin, and Adipose Tissue 63 similar entities Type: Startup Activities: deeptech industry 4.0 Technologies: Synthetic Biology | 6 | 11 |
 | Kolibri Playing music to cells Kolibri revolutionises the way we grow and engineer cells at scale using acoustic waves. 🔍 Book a discovery call: https://calendly.com/tamsin_kolibrilab/discovery-call Showing 10x increase in cell density and 50x reduction in production costs, our patented bioreactors help our partners in drug development unlock patient access to gene therapies, with a proof of principle in AAV gene therapy. Being cell-agnostic and scalable, our process has significant potential across a range of high-value cell-based therapies - or in the cellular agriculture space more broadly. gene therapy, biomanufacturing, cellculture, acoustics, hardtech, and biotech 137 similar entities Type: Startup Activities: biotech deeptech manufacturing Technologies: Synthetic Biology | 14 | 13 |
 | IPRASENSE Cell Culture Monitoring Instruments IPRASENSE revolutionizes cell analysis with innovative technologies for automated cell counting and real-time visualization, ideal for research and quality control. Cell culture monitoring, Lensless Lensfree Imaging, Video microscopy, Time lapse Imaging, Automatic cell count and viability analysis, High throughput cell, Inside your incubator, cell count, cell counting, cell viability, cell viability analysis , cell monitoring, and angiogenesis 103 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 4 | 5 |
 | Egle Therapeutics Modulating T-regulatory cells to balance immunity Egle Therapeutics has been founded with a vision to become a game changer in the field of immunomodulating T-regulatory cells (Tregs) through the unique concept of Tregs’ starving while specifically targeting the most immunosuppressive ones. 185 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 3 | 45 |
 | SingCell A stem cells Contract Development and Manufacturing Organisation (CDMO) in Singapore. MSC, iPSC, clean meat. SingCell offers process development and contract manufacturing services for stem cell therapy and clean meat companies. SingCell leverages its proprietary technology to improve manufacturing processes and offer high consistent quality stem cells. #cleanmeat #celltherapy 14 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 0 | 1 |
 | Cellistic Delivering the iPSC platforms that ready the world for next-gen cell therapies Launched in April 2022, Cellistic specializes in process development and manufacture of cell therapies based on human induced pluripotent stem cell (iPSC) technology. The company’s focus and expertise in iPSC generation and differentiation protocol development makes it well-positioned to partner with innovative cell therapy developers to establish novel advanced therapies. With more than a decade of scientific and technical knowledge transfer from sister company Ncardia, Cellistic is uniquely experienced in designing and optimizing manufacturing procedures for iPSCs that deliver quality products at scale. For more information, visit www.cellistic.com. 59 similar entities Type: SMB Activities: deeptech biotech Technologies: Synthetic Biology | 0 | 88 |
 | CellRev Media additives to improve cell culture efficiency I Biotools Innovator Cohort Member 2024 CellRev provides media additives to optimise and intensify cell culture processes. Low-yield high-cost cell culture is the reality. This is costing the industry billions, resulting in high cost of goods and difficult process translation. CellRev fix ‘sticky cell’ bottlenecks such as aggregation, clumping, and cell detachment to transform process yield. Our principal product, AggreGuardTM, controls cell-to-cell attachment which is typically associated with initiating aggregation in microcarrier culture. AggreGuardTM does not affect cell-to-surface attachment. Bioprocessing, Adherent Cell Culture, Process Engineering, Cell Biology, Cell Growth, and High-Density Processing 35 similar entities Type: SMB Activities: deeptech Technologies: Synthetic Biology | 6 | 10 |
 | VIVOLTA Guiding the body to heal itself VIVOLTA is the healthcare industry’s trusted partner for contract development and manufacturing of electrospun medical products that guide the body to heal itself. Founded in 2008, we leverage our proud heritage as high-performance electrospinning equipment designer now as a leading CDMO for electrospun medical devices and drug delivery systems. Electrospinning, Nanotechnology, Biomaterials, MedTech, Medical Devices, Tissue Engineering Scaffolds, Medical Solutions, Polymers, Nanofibers, GMP, Scalable Manufacturing, Co-Development, Regenerative Medicine, Drug Delivery Solutions, Nanofibers, Tissue Engineering, Medical Electrospinning, Cardiovascular Devices, Sports Medicine Devices, General Surgery Soft Tissue Reconstruction, and MediSpin 74 similar entities Type: SMB Activities: manufacturing deeptech healthtech Technologies: Synthetic Biology | 0 | 35 |
 | NAVAN Transforming Cell Therapy Engineering NAVAN Technologies, Inc. is an enabling technology company commercializing a novel non-viral delivery platform to radically accelerate genetic engineering of human stem & primary cells. The patented NanoStraw technology provides direct intracellular access into hard-to-transfect stem & primary human cells for efficacious delivery of any cargo. By using a physical, non-perturbative mechanism for delivery, the challenges of viral-based cell manufacturing (time, cost and technical difficulties) are eliminated, resulting in fewer, faster operational steps. For more information on NAVAN, please visit www.navanbio.com. 9 similar entities Type: Startup Activities: deeptech Technologies: Synthetic Biology | 1 | 10 |
 |  KDBIO s.a.s. European Distributor of innovative cell culture products KDBIO is distributing advanced cell culture devices used for producing monoclonal antibodies, and 3D culture plates for generating multiple spheroid replicates per well, as well as 3D culture plates with nanofiber scaffolds. G-Rex culture systems can be purchased from KDBIO in the EU. Distribution, monoclonal antibodies, 3D culture, CAR-T, and Patient-derived spheroids 54 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 0 | 1 |
 | SYNTHELIS Cell-free systems expert ! The futures of protein ! Best chance for your protein projects ! A French biotech company located in Grenoble, at the heart of the French Alps, Synthelis is the leading French expert in Cell-Free systems. Our proprietary cell-free expression technology has established itself as a benchmark across Europe and is now on a path to compete with US leaders in the field. The need to produce every possible type of protein quickly, reliably and economically is a real challenge in research fields today, and it will become increasingly important to industry in the decades to come. … 61 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 18 | 9 |
 | BOOST Pharma Treating the untreatable BOOST Pharma is based on years of collaborative research from Karolinska Institute in Stockholm with the focus on novel cell therapy treatments for Osteogenesis Imperfecta. The research teams of associate professor Cecilia Götherström and professor Magnus Westgren have shown that that treatment with BOOST Cells greatly enhanced the quality of life for patients suffering from this otherwise extremely debilitating disease. 63 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 1 | 8 |
 | LIfT BioSciences The world’s only alpha neutrophil cell therapy platform is being used to destroy all solid tumours. LIfT Biosciences is a biotech bringing to market a first-in-class alpha neutrophil cell therapy that overcomes the limitations of current therapies in solid tumours by destroying tumours both directly and indirectly. LIfT’s Immunomodulatory Alpha Neutrophils (IMANs) turn the tumour microenvironment against the tumour as they recruit the rest of the immune system to destroy the tumour to give a durable response and lasting immunity. The patented breakthrough N-LIfT platform is produced from a patented process using exceptional stem cells (iPSC or HSC), a proprietary … 59 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 1 | 23 |
 | Laevoroc Revolutionizing treatment for leukaemia relapse. Spearheading the development of a novel PNP inhibitor poised to revolutionize treatment for leukaemia patients facing relapse post-stem cell transplantation. Oncology 59 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 0 | 3 |
 | Locate Bio Ltd Reshaping rhBMP-2 Perspectives Relieving suffering and improving quality of life with next-generation orthobiologics. Regenerative Medicine, Biomaterials, Medical devices, Drug delivery, biotechnology, BMP2, Programmed Drug Release, and Instructive Tissue Scaffolds 194 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 0 | 24 |
 | Secretome Therapeutics Revolutionizing cell therapy for inflammatory diseases via neonatal cardiac progenitor cells and their secretomes Revolutionizing cell therapy to address inflammatory diseases driven via neonatal cardiac progenitor cells and their secretomes. 260 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 0 | 14 |
 | Cradle Design better proteins. We believe Cells can theoretically produce almost anything, from fabrics to food, fuel and medicines. Designing cell-factories is hard, but our tools and machine-learning models can make it easier. Our mission is to ultimately help replace traditional farms and factories for a more sustainable world. Jobs: https://jobs.cradle.bio protein design, machine learning, protein activity, protein stability, protein secretability, protein , protein structure, metabolic engineering, protein engineering, and protein solubility 79 similar entities Type: Startup Activities: biotech Technologies: Synthetic Biology | 5 | 84 |
 | Cell BioEngines, Inc ‘Off-the-Shelf’ Curative Cell Therapies About Us: Cell BioEngines, Inc., founded in Dec 2022, is a clinical-stage biotech company focused on developing allogeneic 'off-the-shelf' stem cell and its derived therapies as ‘drugs’ for human disease treatment. The company utilizes a ‘plug-and-play’ proprietary platform technology that transforms universal ‘non-gene-modified’ donor blood stem cells from umbilical cord, to produce high-quality, pure and potent, multiple clinical grade cells at scale. This innovative method aims to make stem cells and its derived therapies more accessible and efficient. Its lead product is currently in Phase 1 trials for the treatment of hematopoetiic neoplasms not curable with … 75 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 4 | 2 |
 | Sarcura Powering New Possibles in Cell Therapy Manufacturing Cell therapy has transformed cancer treatment, yet the hurdles of manufacturing patient-derived cell therapies remain a formidable challenge for the industry. Quality and scalability problems lead to high therapeutic costs and limit access to those life-saving treatments. By harnessing the power of cutting-edge semiconductor technologies, including silicon photonics seamlessly integrated into microfluidic cartridges, Sarcura is orchestrating a transformative shift. Central to Sarcura's mission is the creation of fully automated manufacturing systems endowed with real-time process and product control. This pioneering platform promises to usher in a new era of cost-effective and secure cell … 20 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 1 | 28 |
 | OXGENE A WuXi Advanced Therapies company, based in Oxford, UK. OXGENE, a WuXi Advanced Therapies (WuXi ATU) company, based in Oxford, UK, provides cell and gene therapy pioneers around the world with the technologies, automation platforms and service solutions they need to come first in the race to deliver ground-breaking therapeutics. OXGENETM is headquartered in Oxford, UK. For additional information, please visit our website. PRODUCTS: Largest collection of standardised plasmids on the market and SERVICES: DNA Services, Protein Production Services, Virus Services, Cell Line Development Services. 52 similar entities Type: Startup Activities: deeptech Technologies: Synthetic Biology | 5 | 26 |
 | TENSIVE SRL Advanced Biomaterials for Regenerative Medicine Tensive is a biomedical company developing advanced biomaterials for regenerative medicine applications, with a current focus on reconstructive surgery after breast cancer. 122 similar entities Type: Startup Activities: deeptech healthtech Technologies: New Materials Synthetic Biology | 0 | 30 |
 | HemostOD Inspired by platelet biology to save lives. We engineer and manufacture platelets. platelets, biotechnology, bioengineering, stem cells, on demand, biodrug, in vitro manufacturing, Bioprocess, blood platelets, alloimmunization, thrombocytopenia, blood cancer, leukemia, transfusion, HSCT, Stem cell, Hematology, biologics, drug, biopharma, drug development, healthcare, allogenic therapy, drug delivery, miRNA, siRNA, targeted delivery, and targeted drug delivery 62 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 3 | 10 |
 | Immunocore Science to Transform Lives Immunocore is a leading T cell receptor (TCR) biotechnology company working to create first-in-class biological therapies to address unmet patient needs in oncology as well as infectious and autoimmune diseases. See our community guidelines: http://bit.ly/2kFA8hr Biotechnology, Cancer, Oncology, Infectious Diseases, Autoimmune Diseases, T Cell Receptor, Immunotherapy, ImmTAX, ImmTAC, ImmTAV, and ImmTAAI 264 similar entities Type: Startup Activities: deeptech hrtech biotech Technologies: Synthetic Biology | 10 | 574 |
 | Tiss'You Tiss’You – Regenerative Company – researches and develops medical devices to upgrade your body’s natural healing ability Tiss'You - Regenerative Company - researches and develops medical devices for regenerative medicine to help doctors and patients with innovative therapeutical solutions. Tiss'You is also a production facility of 850 sqm of which 240 sqm are clean rooms. We have next-generation equipments for R&D, production and quality control; 2 patents, 4 tissue substitutes and 2 point-of-care cell therapy devices. medicina rigenerativa, ricerca e sviluppo, clinica privata, prevenzione, innovazione, ortopedia, chirurgia vascolare, wound healing, lipocell, monocytes, integratori alimentari, regenerative medicine, food supplements, biomaterials, medical … 92 similar entities Type: Startup Activities: deeptech biotech healthtech Technologies: Synthetic Biology | 1 | 10 |
 | CytoSeek A cell-therapy technology company developing artificial membrane-binding proteins for oncology and regenerative medicine CytoSeek's mission is to use cell membrane augmentation technology to unlock the potential of next generation advanced therapies. Our novel cell membrane augmentation technology enables us to add new functionalities to various therapeutic cells. CytoSeek is engaged in proof of principle studies to demonstrate enhancement of cell therapies for cancer. We are looking to partner with cell therapy companies to bring these products to the clinic and ultimately enhance human health. Biochemistry, Immunology, Oncology, Regenerative Medicine, Cell therapies, and Proteins 81 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 0 | 5 |
 | Cellvax Cellvax, founded in 2001, is a preclinical biotech company which provides in vitro and in vivo studies allowing accelera Cellvax, founded in 2001, is a preclinical CRO which provides innovating drug validation studies both in vitro and in vivo allowing to accelerate the drug development process for unmet needs related to severe human diseases, mainly in Cancer and Osteoarthritis (OA) fields. Cellvax is a fast-growing technology-driven preclinical service company. Today, Cellvax directly employs and through R&D collaborations motivated and differently skilled scientists and engineers, working in interdisciplinary teams on several innovative products. Preclinical studies CRO, Animal models, Cancer, Osteoarthritis, Bio-markers, … 64 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 0 | 7 |
 | GENEPEP - PEPTIDE Peptide Chemistry company for design, synthesis, stability studies and chemical optimisation (SAR studies)- CIR agrement PEPTIDES, PEPTIDE LIBRARIES AND PROTEINS Innovative chemistry for therapeutic, diagnostic and cosmetic applications GENEPEP is a CRO company (with CIR agreement) focused on peptide synthesis & services : - Tools for nanoparticles & surface functionalization - Custom synthesis of peptides, proteins & peptide libraries - Catalog of toxins, peptides & pseudopeptides - Design & synthesis for SAR studies (optimisation of solubility, stability, efficacy,...) - Stability & solubility tests - Partner of European programs, ANR, FUI etc... 375 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 2 | 14 |
 | DiscoveryOrtho Partners A Technology Development and Advisory Company Focused on Medical Devices/Biologics Strategic Advisory Services for both large & small medical device/biologics companies including acquisition, licensing, distribution, joint venture agreements Market, Scientific and Clinical Due Diligence Services Business development Services for venture capital, private equity, hedge funds and investment banking clients & their portfolio companies and clients Product/Device development Strategic Product Postioning including licensing, distribtution and market positioning New Company Formation 520 similar entities Type: SMB Activities: biotech deeptech healthtech Technologies: Synthetic Biology | 0 | 2 |
 | Maxion Therapeutics Ion channel and GPCR drug discovery using innovative KnotBody technology Maxion uses its innovative KnotBody technology in combination with in vitro display technologies to generate therapeutic candidates against ion channels and GPCR proteins. 186 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 1 | 35 |
 | AAVantgarde Bio Delivering the next generation gene therapies AAVantgarde is a clinical-stage, international biotechnology company (headquartered in Italy) that has developed two proprietary adeno-associated viral (AAV) vector platforms to address the DNA cargo capacity limitations of AAV vectors Gene Therapy, Ophthalmology, and Rare diseases 338 similar entities Type: Startup Activities: healthtech biotech deeptech Technologies: Synthetic Biology | 1 | 51 |
 | Cellesce Ltd Cellesce specialises in the development, scale up and manufacture of PDOs (patient-derived organoids) Cellesce Ltd is a biochemical engineering company based in Cardiff in the UK. Cellesce specialises in the development, scale up and manufacture of organoids (PDOs). Cell expansion, Organoid culture, Drug discovery, Oncology, Bioprocess, and 3D Cell Culture 64 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 2 | 2 |
 | Newrotex Ltd UK SME, exploiting the regenerative properties of silk for peripheral nerve repair Newrotex is an Oxford-based SME that has developed an off-the-shelf silk-based conduit for the repair of peripheral nerve injuries. Peripheral Nerve Injury, Silk, Medical Device, Regenerative Medicine, and Biotech 80 similar entities Type: Startup Activities: biotech healthtech Technologies: Synthetic Biology | 1 | 7 |
 | MaSTherCell Now a part of Catalent Cell & Gene Therapy With deep experience in viral vector scale-up and production, Catalent Cell & Gene Therapy is a full-service partner for adeno-associated virus (AAV) and lentiviral vectors, and CAR-T immunotherapies. When it acquired MaSTherCell, Catalent added expertise in autologous and allogeneic cell therapy development and manufacturing to position it as a premier technology, development and manufacturing partner for innovators across the entire field of advanced biotherapeutics. Catalent has a global cell and gene therapy network of dedicated, large-scale clinical and commercial manufacturing facilities, and fill-finish and packaging capabilities located in both the U.S. … 27 similar entities Type: Startup Activities: deeptech manufacturing biotech Technologies: Synthetic Biology | 1 | 26 |
 | Cellevate AB Innovative biotech company developing next generation of cell culture systems designed to revolutionize biomanufacturing Cellevate develops and markets products based on a proprietary nanofiber-based platform - the Cellevat3dTM - with the potential to revolutionize upstream bioprocessing from R&D to commercial manufacturing. Our latest product line in development – Cellevat3dTM carriers – with a commercial launch planned for 2024, provides extracellular-like environments with exceptional surface areas for adherent cell cultures. Initial results show tremendous potential to increase yields, minimize risk and reduce costs in development and manufacturing. We offer a range of products based on our versatile and easily functionalized platform … 58 similar entities Type: Startup Activities: deeptech Technologies: Synthetic Biology | 2 | 32 |
 | Cellsway Cellsway is a fresh deep-tech start-up founded in March 2020 in UK to convert the know-how and cutting-edge core technology that have been developed and cultivated at Mikro Biyosistemler Inc. into commercial products to set the gold standard for diagnosis and management of cancer. The flagship product of the company is a liquid biopsy platform which uses a simple blood sample for cancer diagnostics and cancer research. The patent-pending microfluidic technology enables isolation and enumeration of Circulating Tumor Cells (CTCs) from the blood samples of cancer patients. 68 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 4 | 6 |
 | ResoTher Pharma Building on innovative science to create treatments for patients in need ResoTher Pharma ApS is a biotechnology company focused on developing novel and effective peptide therapeutics for cardiovascular disease by targeting inflammation. Biotechnology, Drug Development, and Pharmaceutical Industry 662 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 0 | 17 |
 | Clean Cells Solution for biologics Clean Cells is a GMP-licensed Contract Development and Manufacturing Organization providing R&D, production and quality control testing services to the biopharmaceutical industry. Our two-part site located in Western France holds an innovative process development platform, BSL2 and BSL3 GMP manufacturing laboratories and analytical areas to develop bespoke assays and perform GMP testing. Clean Cells is part of the Clean Biologics group and benefits from the additional experience of sister company Naobios, a CDMO with considerable experience in the development and manufacture of virus-based products. biosafety testing, Cell Banking and Storage, Viral Clearance, Potency Assay, R&D Contract, Training, … 83 similar entities Type: SMB Activities: biotech Technologies: Synthetic Biology | 11 | 123 |
 | Just - Evotec Biologics Designing and applying innovative technologies to dramatically expand global access to biotherapeutics. Just – Evotec Biologics, wholly owned by Evotec SE, is a first-to-industry biologics platform that leverages AI/ML technologies and world-leading molecular design, cell line development, process intensification and continuous manufacturing strategies to advance biotherapeutics from discovery through clinical stages to commercial launch. The Just – Evotec Biologics team combines deep industry experience in the fields of data, protein, process, and manufacturing sciences including automation with highly integrated and flexible capabilities to break through the scientific and economic barriers associated with the development of protein therapeutics. Our focus is … 173 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 6 | 611 |
 | HP Health Solutions For more information, please visit www.gna-bio.com Laser PCR, Molecular Diagnostics, OEM, Molecular Technology, Biosecurity, Life Sciences, Food Safety, Nucleic Acid Amplification, Molecular Assays, Biotechnology, and Nanotechnology 265 similar entities Type: Startup Activities: deeptech biotech nanotech Technologies: Synthetic Biology | 1 | 32 |
 | CellVoyant We see the future in cells CellVoyant is an AI-first biotechnology company with a mission to create novel stem cell-based therapies for chronic diseases. Our technology uses AI-first live cell imaging to predict and optimise stem cell differentiation, to controllably manufacture any cell and tissue in the body at scale. CellVoyant is built on foundational work from the Carazo Salas lab at the University of Bristol. We’re working at the exciting intersection of cell biology, computer vision, engineering, and machine learning to industrialise next-generation science from research into the real world. Our mission is bold and ambitious and we have … 71 similar entities Type: Startup Activities: deeptech biotech Technologies: A.I. Synthetic Biology | 4 | 17 |
 | AFFIRMA BIOTECH SL Affirma Biotech develops new products to overcome the challenge of Multi Drug Resistant and Chronic Infections Affirma Biotech is a start-up company specialized in the discovery and development of new anti-infective drugs via immunomodulation. 438 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 0 | 5 |
 | CellAction Cell therapy Acceleration and Innovation: Rethinking cell & gene therapy By Institut Curie CellAction (Cell therapy Acceleration and Innovation) is the cell and gene therapy platform of the Paris-Saclay Cancer Cluster (PSCC) at Institut Curie. A first in France, CellAction enables collaborative projects to be launched with industrial partners on a national and international scale. The aim is to accelerate the development of optimized cell and gene therapies. CellAction is founded on the centralization of key expertise required for the drug development process: - Institut Curie's highly qualified medical-scientific teams - Cutting-edge technologies for in vitro and in vivo testing … Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 8 | 6 |
 | gradiant bioconvergence It is a company that is the first agency that has a global scale -derived organoid. Based on more than 400 organoid banking systems, garden -based platforms using autoimmune systems, genome analysis -based genetic variations, disease modeling using genetic scissors, and developing new drug -based growth factors based on ECM -based ECM -based growth factors, cooperation with leading domestic and overseas companies and institutions in the field of tumor and regenerative medicine. there is. 92 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 1 | 10 |
 | Cellaïon Cell Signaling Technology for Organ Repair and Regeneration Cell Signaling Technology for Organ Repair and Regeneration We care for liver Our advanced therapy aims to restore liver function thanks to immunomodulatory and regenerative properties of Hepastem Cell therapy, Acquired liver diseases, Liver diseases, liver based genetic diseases, NASH, ACLF, Antibodies, Clinical stage, Chronic liver disease, Fatty liver, Acute liver disease, Regenerative medicine, Biotech, and Biotechnology 155 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 2 | 20 |
 | Abcell-bio Human primary cells to enhance your research Specialized in cell culture, Abcell-bio has a 10-year background and experience in Stem Cell Research and Development. Abcell-bio team is composed of experts that can advise you for your research projects. Our technical team is trained to produce high-quality products in the fields of hematopoiesis and vascular biology. We can process several cell types extracted from: * Cord Blood: CD34+ cells, CD133+ cells, CD34- cells, MonoNuclear Cells (MNCs), Endothelial Progenitor Cells (EPCs) * Umbilical Cord (Human Umbilical Vein/Arterial Endothelial Cells (HUVEC, HUAEC) We also created Cell Culture Media to match your needs for … 40 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 1 | 8 |
 | 64x Bio An evolution in cell line engineering. High throughput engineering of cell lines to enhance the design and manufacture of next-generation therapeutics. Gene therapy, Synthetic Biology, Genome Engineering, and Functional Genomics 171 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 4 | 22 |
 | Harness Therapeutics Unlocking New Targets to Transform the Treatment of Neurodegenerative Diseases Unlocking New Targets to Transform the Treatment of Neurodegenerative Diseases neurodegeneration, RNA therapeutics, physiological upregulation, post-transcriptional upregulation, mRNA, ASO, and SINEUP 279 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 1 | 32 |
 | StemSight - Vision Unlimited Curing blindness with regenerative cell therapies. StemSight develops off-the-shelf regenerative cell therapies for corneal blindness. Our expertise is in the combination of iPS-derived cells with functional biomaterials - for FASTER tissue regeneration, SAFER cell therapies and EASIER cell delivery. 30 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 1 | 16 |
 | Zelluna Developing allogeneic TCR-NK therapies for solid tumors Zelluna Immunotherapy is a company pioneering the development of allogeneic T cell receptor (TCR) guided natural killer (NK) cell immunotherapies for the treatment of solid cancers. The company is developing a portfolio of tumor specific TCRs to guide NK cells with the aim to induce cancer responses that are safe, efficient and durable. For more info please visit www.zelluna.com Cancer treatment, Immunotherapy, Adoptive cell therapy, T cell receptor technologies, Immunooncology, and Solid tumors Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 1 | 30 |
 | Immitra Bio GmbH We turn blood stem cells into living drug factories At Immitra Bio, we are pioneering a next-generation gene therapy platform, harnessing Hematopoietic Stem Cells and their downstream cell lineages, such as red blood cells as living, in-vivo biotherapeutic protein factories. The CRISPR-Cas-based cell and gene therapy platform we are developing is versatile and promises to be easily reprogrammable. 221 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 0 | 4 |
 | Bioscibex At Bioscibex, we are redefining bioprocessing with innovative single-use bioreactor solutions tailored for modern biologics and cell therapy manufacturing. Our mission is to empower researchers and manufacturers with tools that simplify processes, enhance scalability, and improve efficiency. 260 similar entities Type: Startup Activities: deeptech Technologies: Synthetic Biology | 3 | 5 |
 | mo:re The efficient alternative to animal studies Your new teammate in the lab! Our lab platform takes over tedious and error-prone manual tasks in 3D cell culture, aiming to replace animal studies. A standardised repository of protocols lets you set up new experiments within minutes. Our AI-based quality control provides real-time transparency on the state of your cell culture, allowing you to worry less and make well-informed decisions. Automation, Biotechnology, Hydrogels, Cell Culture, and Organoids 66 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology A.I. Robotics | 2 | 10 |
 | BioNTech IMFS BioNTech Innovative Manufacturing Services (IMFS) is a subsidary of BioNTech SE. We are specialized in the development and production of innovative products (viral vectors, cells and ivt mRNA). Based on extensive expertise in scientific, technical and regulatory prerequisites, we develop and manufacture your products in a safe and cost-efficient way in our state-of-the-art GMP facilities. We offer contract services for retroviral vector manufacturing for clinical supply. The company has more than 500 experienced and highly skilled employees and is always looking for motivated people! See also www.biontech-imfs.de Cell therapy, GMP manufacturing, Gene Therapy, RNA manufacturing, Retroviral vector manufacturing, Contract Manufacturing, … 115 similar entities Type: SMB Activities: deeptech biotech Technologies: Synthetic Biology | 0 | 255 |
 | Limula Cell & Gene Therapy: Automated. Scalable. Accessible Limula provides an innovative solution for the production of the most personalised cancer treatments on demand and at scale. Our product is a unique proprietary platform can perform multiple steps of cell therapy manufacturing in a single device, using end-to-end automation and integrated process analytics. Bioproduction, Immunooncology, Cell therapy, Biotechnolgoy, Manufacturing, and CAR-T 131 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 6 | 28 |
 | Personalized Stem Cells, Inc StemInsure®: Your Younger Cells For Life® Personalized Stem Cells, Inc. (PSC) is raising the standard of Stem Cell therapy. We are committed to providing high-quality stem cell processing services, as well as excellent technical, clinical, and regulatory support to physicians, clinical investigators, and patients. 61 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 0 | 4 |
 | AGECURVE LIMITED Cell Tree Analytics, somatic mutation tracking, clonal structure quantification, check out our Cell Tree Rings study here https://www.biorxiv.org/content/10.1101/2022.12.14.520419v1 mass spec proteomics, aging 68 similar entities Type: Startup Activities: deeptech greentech Technologies: Synthetic Biology | 1 | 1 |
 | Bioretec Ltd. better healing - better life Bioretec Ltd. is a medical device company focusing on the development of strong, safe and reliable absorbable and bioresorbable implants for pediatric and adult orthopaedics. Our products are used worldwide, and we continue to further develop materials and products for load-bearing clinical applications. biomaterials, medical, manufacturing, medical devices, implants, absorbable metal, biopolymers, orthopaedics, and pediatric surgery 215 similar entities Type: SMB Activities: manufacturing deeptech healthtech Technologies: Synthetic Biology | 0 | 47 |
 | Mallia Therapeutics Mallia Therapeutics is a biopharmaceutical company developing soluble CD83 (sCD83) for the treatment of hair loss Mallia Therapeutics is a biopharmaceutical company developing soluble CD83 (sCD83) for the treatment of hair loss 133 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 1 | 5 |
 | MaxCyte, Inc. Let's Build Better Cells Together We invest in our partners early on, working side by side in optimizing their processes to derisk their path to the clinic faster. Our ExPERTTM platform, which is based on our Flow Electroporation® technology, has been designed to support the rapidly expanding cell therapy market and can be utilized across the continuum of the high-growth cell therapy sector, from discovery and development through commercialization of next-generation, cell-based medicines. The ExPERT family of products includes: four instruments, the ATxTM, STxTM, GTxTM and VLx TM; a portfolio of proprietary related processing assemblies or disposables; and software protocols, … 313 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 4 | 131 |